Rhegmatogenous retinal detachment with a high risk of proliferative vitreoretinopathy treated with episcleral surgery and an intravitreal dexamethasone 0.7-mg implant

Case Reports in Ophthalmology

Volumn 4, Issue 1, 2013, Pages 79-83

  Reibaldi, Michele ^a   Russo, Andrea ^a   Longo, Antonio ^a   Bonfiglio, Vincenza ^a   Uva, Maurizio G ^a   Gagliano, Caterina ^b   Toro, Mario D ^a   Avitabile, Teresio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b Department of Ophthalmology ^*  (Italy)

Author keywords

Dexamethasone 0.7 mg; Episcleral surgery; Ozurdex ; Proliferative vitreoretinopathy; Retinal detachment

Indexed keywords

DEXAMETHASONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CRYOTHERAPY; DRUG IMPLANTATION; HUMAN; MALE; OFF LABEL DRUG USE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETINA DETACHMENT; RETINOPEXY; SCLERECTOMY; TREATMENT OUTCOME; VISUAL ACUITY; VITREORETINOPATHY; ABSENCE OF COMPLICATIONS; CLINICAL EFFECTIVENESS; DRUG DELIVERY DEVICE; EPISCLERAL SURGERY; EYE INJURY; EYE SURGERY; INTRAOCULAR PRESSURE; SCLERAL BUCKLING SURGERY; SUSTAINED DRUG RELEASE;

EID: 84877976578     PISSN: None     EISSN: 16632699     Source Type: Journal    
DOI: 10.1159/000351176     Document Type: Article

References (15)

1. Sethi CS, Lewis GP, Fisher SK, Leitner WP, Mann DL, Luthert PJ, Charteris DG: Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 2005;46:329-342. (Pubitemid 40041216)
2. Rodriguez de la Rúa E, Pastor JC, Aragón J, Mayo-Iscar A, Martínez V, García-Arumí J, Giraldo A, Sanabria-Ruiz Colmenares MR, Miranda I: Interaction between surgical procedure for repairing retinal detachment and clinical risk factors for proliferative vitreoretinopathy. Curr Eye Res 2005;30:147-153. (Pubitemid 40516090)
3. Abrams GW, Azen SP, McCuen BW 2nd, Flynn HW Jr, Lai MY, Ryan SJ: Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: results of additional and long-term follow-up. Silicone Study report 11. Arch Ophthalmol 1997;115:335-344.
4. Chen W, Chen H, Hou P, Fok A, Hu Y, Lam DS: Midterm results of low-dose intravitreal triamcinolone as adjunctive treatment for proliferative vitreoretinopathy. Retina 2011;31:1137-1142.
5. Ahmadieh H, Feghhi M, Tabatabaei H, Shoeibi N, Ramezani A, Mohebbi MR: Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial. Ophthalmology 2008;115:1938-1943.
6. Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M: Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 2006;113:1533-1538. (Pubitemid 44292310)
7. Herrero-Vanell R, Cardillo JA, Kuppermann BD: Clinical applications for the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol 2011;5:139-146.
8. Reibaldi M, Russo A, Zagari M, Toro M, De Grande V, Cifalinò V, Rametta S, Faro S, Longo A: Resolution of persistent cystoid macular edema due to central retinal vein occlusion in a vitrectomized eye following intravitreal implant of dexamethasone 0.7 mg. Case Rep Ophthalmol 2012;3:30-34.
9. Russo A, Avitabile T, Uva M, Faro S, Franco L, Sanfilippo M, Gulisano S, Toro M, De Grande V, Rametta S, Foti L, Longo A, Reibaldi M: Radiation macular edema after Ru-106 plaque brachytherapy for choroidal melanoma resolved by an intravitreal dexamethasone 0.7-mg implant. Case Rep Ophthalmol 2012;3:71-76.
10. Girard P, Mimoun G, Karpouzas I, Montefiore G: Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina 1994;14:417-424.
11. Duquesne N, Bonnet M, Adeleine P: Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol 1996;234:677-682. (Pubitemid 26387909)
12. Sundaram V, Barsam A, Virgili G: Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery. Cochrane Database Syst Rev 2013;1:CD006421.
13. Koerner F, Merz A, Gloor B, Wagner E: Postoperative retinal fibrosis-a controlled clinical study of systemic steroid therapy. Graefes Arch Clin Exp Ophthalmol 1982;219:268-271. (Pubitemid 13171091)
14. Williams RG, Chang S, Comaratta MR, Simoni G: Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy? Graefes Arch Clin Exp Ophthalmol 1996;234:496-503.
15. Bali E, Feron EJ, Peperkamp E, Veckeneer M, Mulder PG, van Meurs JC: The effect of a preoperative subconjuntival injection of dexamethasone on blood-retinal barrier breakdown following scleral buckling retinal detachment surgery: a prospective randomized placebo-controlled double blind clinical trial. Graefes Arch Clin Exp Ophthalmol 2010;248:957-962.